3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
6
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
18
Hematologic Neoplasms
3
Neoplasms, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Diseases
1
Heart Failure, Systolic
1
Acute-Phase Reaction
1
Interventions
Watchful Waiting
2
Blood Specimen Collection
2
Vital Signs
1
Specimen Handling
1
Rituximab
1
Observation
1
Interviews as Topic
1
Flow Cytometry
1
Filgrastim
1
Data Collection
1
COVID-19 Vaccines
1
Bortezomib
1
Blood Viscosity
1
Albumins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hematologic Diseases
×
Bortezomib
×
Clear all
NCT07200583
2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
50 enrolled